Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1294
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT06543537 | Pilot Randomized Controlled Trial of a Collaborative Agenda-setting Intervention (CASI) for Patients With Ovarian Cancer | ||
| NCT02466061 | TREC Lifestyle Beyond Cancer Study in Endometrial Cancer Survivors | ||
| NCT00146601 | Fulvestrant in Premenopausal Women With Hormone Receptor-Positive Breast Cancer | ||
| NCT05168930 | Zanubrutinib and Venetoclax in CLL (ZANU-VEN) | ||
| NCT04115059 | Dasatinib In Waldenström Macroglobulinemia | ||
| NCT01955395 | Genomic and Psychosocial Effects of the 3RP on Patients With MGUS and Smoldering Multiple Myeloma | ||
| NCT00601120 | RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma | ||
| NCT02853500 | Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies | ||
| NCT02452710 | Harnessing the Effect of an Open-Label Placebo on Fatigue in Cancer Survivors | ||
| NCT00372515 | High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations | ||
| NCT01319591 | Comparison of Creatinine Clearance Calculation for Estimation of GFR in Patients Receiving HD Methotrexate | ||
| NCT00911820 | Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer | ||
| NCT00299780 | Safety Study of Parathyroid Hormone in Patients Needing Additional Stem Cell Mobilization. | ||
| NCT00852462 | Lung Cancer Symptom Assessment and Management Intervention | ||
| NCT03641755 | Olaparib + Sapacitabine in BRCA Mutant Breast Cancer | ||
| NCT02158091 | A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL | ||
| NCT01323920 | Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors | ||
| NCT00006123 | Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer | ||
| NCT00496379 | ZK219477 (Sagopilone) in Patients With Breast Cancer and Brain Metastases | ||
| NCT00140478 | Mifepristone (RU-486) in Androgen Independent Prostate Cancer | ||
| NCT02644382 | Improving Surgical Decision-making in Young Women With Breast Cancer | ||
| NCT03683680 | Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers | ||
| NCT03075527 | A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma | ||
| NCT04305145 | Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis | ||
| NCT00165100 | Dynamic Area Telethermometry (DAT) as an Imaging Modality in Patients With Cancer | ||
| NCT05050305 | Marizomib Central Nervous System (CNS) | ||
| NCT00020605 | Naloxone in Treating Constipation in Patients Who Are Receiving Opioids for Chronic Pain | ||
| NCT00148681 | Preoperative Herceptin and Navelbine for Breast Cancer | ||
| NCT00280930 | Letrozole in Postmenopausal Women at Increased Risk for Breast Cancer | ||
| NCT07052695 | Mosunetuzumab for CLL MRD Clearance | ||
| NCT00622401 | Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12 | ||
| NCT06543511 | MyeloGen: Germline Testing for Predisposition to Myeloid Malignancies | ||
| NCT04197310 | Cabozantinib and Nivolumab for Carcinoid Tumors | ||
| NCT00903162 | Extended Endocrine Therapy for Premenopausal Women With Breast Cancer | ||
| NCT06001762 | TRADE: Dose Escalation Tolerability of Abemaciclib in HR+ HER2- Early Stage Breast Cancer | ||
| NCT05176288 | Avelumab, Palbociclib and Axitinib in Advanced RCC | ||
| NCT02976103 | Reduction of Post Mastectomy Pain With the Jacki® Recovery Jacket | ||
| NCT00374257 | UVB Phototherapy Treatment of Oral Chronic GVHD | ||
| NCT02337491 | Pembrolizumab +/- Bevacizumab for Recurrent GBM | ||
| NCT00268918 | Docetaxel and PTK787 in Metastatic Breast Cancer Patients and Gynecological Cancer Patients | ||
| NCT02036476 | Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma | ||
| NCT05922761 | BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP) | ||
| NCT04851522 | Dilute Bleach Compresses for Radiation Dermatitis | ||
| NCT06986174 | A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia | ||
| NCT00459186 | The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer | ||
| NCT06068075 | Liquid Biopsy in Ewing Sarcoma and Osteosarcoma as a Prognostic And Response Diagnostic: LEOPARD | ||
| NCT00165412 | Breast MRI Screening in Women Treated With Mediastinal Irradiation for Hodgkin's Disease | ||
| NCT06563596 | Epco, Zanu, Ritux for R/R FL or MZL | ||
| NCT06854003 | BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma | ||
| NCT01208662 | Randomized Trial of Lenalidomide, Bortezomib, Dexamethasone vs High-Dose Treatment With SCT in MM Patients up to Age 65 |
